Integrated Nano-Trojan Horse Protocol for Restoring Cellular Communication in Solid Tumors: A Disruptive Conceptual Framework

Background: Solid tumors present formidable therapeutic challenges due to metabolic reprogramming (Warburg effect) and disrupted intercellular communication networks. Conventional cytolytic approaches often fail to address foundational mechanisms of tumor autonomy. Objective: This conceptual paper introduces a novel integrative framework—Nano-Enabled Communication Restoration (NECR)—merging insulin-targeted nanotechnology with near-infrared (NIR)-activated immunomodulation to restore disrupted cellular communication in solid tumors. Methods: We propose a unified mathematical framework with explicit model hierarchy: (1) baseline growth dynamics (Gompertz, logistic, von Bertalanffy); (2) spatial invasion and transport (Fisher-KPP, advection-diffusion); (3) vascular-tumor coupling (Hahnfeldt extension); and (4) treatment-integrated stochastic core. The NECR protocol employs insulin-conjugated nanoparticles (20-100 nm, zeta potential -10 to +10 mV pH-switchable) as Trojan horses to deliver ECM-restorative enzymes and NIR-sensitive modulators. Treatment effects are explicitly incorporated via receptor-limited drug kinetics, pH-triggered release (Henderson-Hasselbalch), photobiomodulation terms, and immune reactivation components. Synthetic data validation follows TCGA-BRCA distributions with hierarchical Bayesian uncertainty quantification and global Sobol sensitivity analysis. Results: In silico Monte Carlo simulations (n=100 runs) under idealized modeling assumptions predict substantial tumor growth suppression, with simulated reductions reaching as high as 96-99.8% at days 40-100 compared to untreated controls. These theoretical upper bounds reflect synergistic mechanisms but require empirical validation. Global sensitivity analysis identifies drug efficacy and NIR potency as dominant parameters, supporting targeted optimization priorities. Conclusions: NECR offers a theoretically rigorous, mechanistically grounded framework for remission induction through nano-light synergy. While experimental validation remains pending, the enhanced mathematical formalism, comprehensive parameterization, and proposed verification roadmap provide a robust foundation for translational development. All derivations, code, and synthetic datasets are provided for reproducibility. Keywords: Cancer therapy; Nanotechnology; Cellular communication; NIR photobiomodulation; Mathematical modeling; Tumor angiogenesis; Bayesian inference; Synthetic data validation